Asia-Pacific Cancer Therapy Market - Growth, Trends, and Forecasts (2016- 2021)

1. Introduction

                1.1 Study Deliverables

                1.2 Market Definition

                1.3 Sizing Units

                1.4 Base Currency

                1.5 Review and Forecast Period Years

                1.6 General Study Assumptions

2. Research Methodology

                2.1 Introduction

                2.2 Analysis Methodology

                2.3 Econometric Forecast Model

                2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

                5.1 Current Market Scenario

                5.2 Applications of Cancer therapeutics

                5.3 Technology Overview

                5.4 New Developments

                5.5 Industry Value-Chain Analysis

                5.6 Product Life-Cycle Analysis

                5.7 Product Benchmarking

                5.8 Investment Analysis

                5.9 Porter’s Five Forces

                                5.9.1 Bargaining Power of Suppliers

                                5.9.2 Bargaining Power of Consumers

                                5.9.3 Threat of New Entrants

                                5.9.4 Threat of Substitute Products and Services

                                5.9.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Drivers

                7.1 Increased Incidence of Cancer

                7.2 Increasing Public Awareness about Diseases and Treatment Options

                7.3 Aging Population

                7.4 Rising Government Initiatives

                7.5 Growing Demand for Advanced Therapies

                7.6 Patent Expiry of Leading Drugs

8. Market Restraints

                8.1 High Prices of Therapies

                8.2 Side-Effects Caused During Treatment

                8.3 Change in Reimbursement Policies

                8.4 Stringent Regulatory Issues

9. Key Challenges

10. Current Opportunities in the Market

11. Market Segmentation

                11.1 By Type

                                11.1.1 Chemotherapy

                                                11.1.1.1 Marketed Drugs

                                                11.1.1.2 Drugs in Pipeline

                                11.1.2 Radiotherapy

                                11.1.3 Hormone Therapy

                                11.1.4 Targeted Cancer Therapy

                                11.1.5 Immunotherapy

                                                11.1.5.1 Monoclonal Antibodies

                                                11.1.5.2 Cancer Vaccines

                                                11.1.5.3 Non-Specific Immunotherapy

                                11.1.6 Combination Therapy

                                11.1.7 Surgery

                11.2 By Disease

                                11.2.1 Lung Cancer

                                11.2.2 Breast Cancer

                                11.2.3 Colorectal Cancer

                                11.2.4 Ovarian Cancer

                                11.2.5 Head and Neck Cancer

                                11.2.6 Stomach Cancer

                                11.2.7 Liver Cancer

                                11.2.8 Others

                11.3 By End-User

                                11.3.1 Hospitals

                                11.3.2 Clinics

                                11.3.3 Research Centers

                11.4 By Geography

                                11.4.1 Asia-Pacific

                                                11.4.1.1 Introduction

                                                11.4.1.2 India

                                                11.4.1.3 China

                                                11.4.1.4 Japan

                                                11.4.1.5 Australia & New Zealand

                                                11.4.1.6 South Korea

12. Competitive Landscape

                12.1 Merger and Acquisition Analysis

                12.2 New Product Launches

                12.3 Agreements, Collaborations & Partnerships

13. Company Profiles

                13.1 Roche

                13.2 Merck

                13.3 Bristol-Myers Squibb

                13.4 Novartis

                13.5 Celgene

                13.6 Teva

                13.7 Pfizer

                13.8 Astra Zeneca

                13.9 Janssen

14. Analyst Outlook for Investment Opportunities

15. Future Outlook of the Market